Healthcare / Health Information ServicesKuala Lumpur
$0.06
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-4.2M · quality 49.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
50/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$45M
P/E
9.5x
↓EV/EBITDA
4.3x
↓ROE
11.6%
↑Gross Margin
17.6%
↓Debt/Equity
0.01
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+14.3%
FCF CAGR
—
FCF margin
11.3%
FCF / Net income
0.40x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $18.4M · net income $5.2M · FCF $2.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $18.4M | $18.4M | $15.9M | $13.6M | $12.3M |
| Net Income | $5.2M | $5.2M | $4.2M | $100901.00 | $-35.1M |
| EBITDA | $6.4M | $6.4M | $7.0M | $3.0M | $-31.0M |
| EPS | 0.01 | 0.01 | 0.01 | 0.00 | -0.06 |
| Gross Margin | 17.6% | 17.6% | 26.8% | 35.6% | 17.7% |
| Operating Margin | -13.0% | -13.0% | -23.4% | -22.0% | -176.3% |
| Net Margin | 28.0% | 28.0% | 26.3% | 0.7% | -284.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 |
| Current Ratio | 6.29 | 6.29 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $2.1M | $2.1M | $-4.2M | $-4.3M | $-5.0M |
| Returns | |||||
| ROE | 11.6% | 11.6% | 9.8% | 0.3% | -138.3% |
| Valuation | |||||
| P/E | 9.46 | 9.46 | 21.24 | 718.75 | — |
| EV/EBITDA | 4.31 | 4.31 | 10.00 | 18.78 | — |
| P/B | 1.01 | 1.01 | 2.07 | 2.22 | 3.46 |
| Growth & Yield | |||||
| Revenue Growth | 15.7% | 15.7% | 17.5% | 9.8% | — |
| EPS Growth | 12.2% | 12.2% | 3431.2% | 100.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-5.7%
EPS terminal req.
$0.01
Spread vs growth
17.9%
5Y implied EPS CAGR
0.3%
EPS terminal req.
$0.01
Spread vs growth
11.9%
10Y implied EPS CAGR
5.0%
EPS terminal req.
$0.01
Spread vs growth
7.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-36.8%
Start / end P/E
16.8x → 9.5x
EPS bridge
0.01 → 0.01
Residual
-5.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.